Antifungal prophylaxis in neutropenic patients with hematologic malignancies.
Böhme
A
A
Medical Clinic III, Hematology/Oncology, J.W. Goethe University, Frankfurt, Germany.
Karthaus
M
M
Hoelzer
D
D
D000935:Antifungal Agents / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001228:Aspergillosis / Q000209:etiology* / Q000517:prevention & control*; D001230:Aspergillus; D002175:Candida; D002177:Candidiasis / Q000209:etiology* / Q000517:prevention & control*; D015725:Fluconazole / Q000008:administration & dosage*; D019337:Hematologic Neoplasms / Q000150:complications / Q000188:drug therapy; D006801:Humans; D017964:Itraconazole / Q000008:administration & dosage*; D009503:Neutropenia / Q000209:etiology*
D000935:Antifungal Agents; D000970:Antineoplastic Agents; D017964:Itraconazole; D015725:Fluconazole